SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: cjgaddy who started this subject10/27/2000 2:28:53 PM
From: Terry D.  Read Replies (1) of 3702
 
Am I reading it right? tFT on it's own is tumor specific? It will localize to a tumor and no other site? A (simplistic view) shot in the arm and it seeks out a tumor? I high lighted these portions in yesterdays post and was surprised that there has been no discussion on it. I am trying to get confirmation on whether my interpretation is correct. Will let ya know.

From the Release:

that tTF is capable of localizing to tumor blood vessels and inducing coagulation (blood clots) of the tumor blood

These new patents encompass the discovery that tTF itself, without a targeting agent, and its ability to coagulate tumor blood vessels. This non-targeted tTF could potentially be used alone, in conjunction with other coagulation proteins or in combination with other anti-cancer agents.

Fairways and Greens

Terry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News